- GP practice
Castle Medical Group
We served a warning notice to Castle Medical Group on 15 September 2026 for failing to meet the regulations relating to safe care and treatment.
Assessment report published 22 October 2026
Contents
Ratings
Our view of the service
Date of Assessment: 31 July 2026. Castle Medical Group is a GP practice and delivers services to approximately 18,000 people under a contract held with NHS England. According to the latest available data, the ethnic make-up of the service area is approximately 96% White, 1.3% Asian, 1.5% Mixed, 0.5% Black and 0.2% Other. Information published by the Office for Health Improvement and Disparities shows deprivation within the service population group is in the 9th decile (9 of 10). The lower the decile, the more deprived the service population is relative to others.
This was a focused assessment. We undertook this assessment due to the length of time since our last assessment. We assessed 12 quality statements from across all 5 key questions. This assessment considered the demographics of the people using the service, the context the service was working within and how this impacted service delivery. Where relevant, further commentary is provided in the quality statements section of this report.
The assessment identified significant concerns regarding the safe management of medicines, patient monitoring and clinical oversight. Reviews of patient records found examples where patients continued to receive treatment despite overdue monitoring requirements, medication reviews had not always been completed appropriately, and follow-up actions were not always undertaken when concerns had been identified. Concerns were also identified in the management of medicines subject to national safety requirements. As a result, patients were exposed to a risk of avoidable harm, and we identified a breach of safe care and treatment which resulted in the issue of a Warning Notice to the provider.
Although the service maintained a clean and safe environment, managed infection prevention and control effectively and ensured equipment was appropriately maintained, medicines were not always managed safely, and people did not always receive care and treatment in line with current evidence-based guidance and best practice. Systems for monitoring patient outcomes had not always operated effectively and risks were not consistently identified, monitored or acted upon.
Patient feedback was generally positive and people described staff as kind, caring and respectful. Performance data demonstrated positive outcomes in some areas, including childhood immunisations and cervical screening. The service had also taken steps to support equitable access and reduce barriers for people with additional needs. However, some patients reported difficulties accessing the service and contacting the practice when required.
Leaders had a clear vision for the service and had begun implementing improvements in response to the concerns identified. However, governance and clinical oversight arrangements had not been effective in identifying and addressing risks relating to medicines management, patient monitoring, follow-up arrangements and staff training compliance. The concerns identified through the assessment had not been recognised through the provider's own systems, which meant leaders could not be assured that patients were consistently receiving safe and effective care and treatment.
People's experience of this service
As part of our assessment, we reviewed feedback from people who used the service to understand their views and experiences. This included reviewing patient feedback and national survey results. People were generally positive about the quality of care and treatment they received and described staff as caring, respectful and compassionate. This was reflected in the results of the 2026 GP Patient Survey, which showed the service performed above the national average in several areas. For example, 98% of respondents said they had confidence and trust in the healthcare professional they saw or spoke to, compared with the national average of 93%. The service also reviewed feedback from people, including complaints, Friends and Family Test results and national survey findings, to identify areas for improvement and improve people's experiences and outcomes.
There was an active patient participation group (PPG) who represented the views of people using the service.